DEC-09-13 The National Viral Hepatitis Roundtable is seeking a candidate with a strong combination of viral hepatitis
knowledge and leadership experience to fill the position of Executive Director.Click here to see the job announcement. The application process is open until January 3,
2014. Resume, cover letter and any questions about the position may be
sent to Martha Saly at email@example.com
DEC-02-13 amfAR, The Foundation
for AIDS Research, and Treatment Action Group (TAG) called for a deliberate and
expedited research agenda designed to begin to end the AIDS epidemic in the
United States. The new report, Filling
the Gaps in the U.S. Treatment Cascade: Developing a Community-Driven Research
Agenda, summarizes key implementation science research priorities
developed at a June 2013 gathering of HIV community activists, researchers and
policy makers, and health care providers. Participants identified critical
areas for research and policy to address gaps in the United States continuum of
HIV care, also known as the HIV treatment cascade.
NOV-25-13 The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given an opinion on the use of daclatasvir in combination with sofosbuvir in the treatment of chronic (long-term) hepatitis C virus (HCV) infection, in a compassionate-use programme. Click here to read the full press release.
NOV-25-13 The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Sovaldi (sofosbuvir) intended for the treatment of chronic hepatitis C. Click here to read the full press release.
NOV-25-13 The U.S. Food and Drug Administration approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Olysio is a protease inhibitor that blocks a specific protein needed by the hepatitis C virus to replicate. It is to be used as a component of a combination antiviral treatment regimen. Click here to read the full press release.